ReviewCurrent opinion in oncology2012

Poly (ADP-ribose) polymerase inhibitors: on the horizon of tailored and personalized therapies for epithelial ovarian cancer.

Elena S Ratner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.